Lonza
The Quality Control Analyst I – Cell Therapy (AM Shift) performs QC biological and cell‑based assays to support release and stability testing of cell therapy products, ensuring compliance with cGMP regulations and accurate laboratory documentation. The role works on a variety of analytical techniques, collaborates with cross‑functional teams, and contributes to technology transfer and method validation projects.
Headquarters
Basel, Basel-Stadt, Switzerland
Company Size
10001+ employees
Founded
1897
Lonza is one of the world’s largest healthcare manufacturing organizations, helping pharmaceutical, biotech and nutrition companies to bring their treatments to market.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Lonza.
Lonza didn’t post a salary, so this is our estimate from similar listings.
28% below the average for this role
Quality Control Analyst II, Cell Therapy (PM Shift)
WayUp
Senior Specialist, QC Analytical, Cell Therapy A2 Shift
Bristol Myers Squibb
Senior Specialist, QC Analytical, Cell Therapy
Bristol Myers Squibb
Principal Scientist, QC Analytical, Cell Therapy
Bristol Myers Squibb
Associate, Quality Control Analytical, Cell Therapy
AstraZeneca
Specialist, QC Analytical, B2 Shift, Cell Therapy
Bristol Myers Squibb